Neuraltus Pharmaceuticals' Series A Round

Neuraltus Pharmaceuticals raised a round of funding on March 18, 2009.

Neuraltus Pharmaceuticals is a privately-held biopharmaceutical company dedicated to developing and commercializing innovative therapeutics that address critical unmet needs for patients and physician…

Articles about Neuraltus Pharmaceuticals' Series A Round: